AUTOLUS THERAPEUTICS PLC's ticker is AUTL and the CUSIP is 05280R100. A total of 67 filers reported holding AUTOLUS THERAPEUTICS PLC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,365,191 | +8.0% | 585,919 | +10.4% | 0.03% | -15.0% |
| Q2 2023 | $1,263,587 | -9.3% | 530,919 | -29.9% | 0.04% | -7.0% |
| Q1 2023 | $1,392,895 | -99.9% | 757,008 | +29.5% | 0.04% | +79.2% |
| Q3 2022 | $1,251,000,000 | -24.3% | 584,406 | +0.0% | 0.02% | 0.0% |
| Q2 2022 | $1,653,000,000 | – | 584,246 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TFG Asset Management GP Ltd | 2,150,000 | $34,465,000 | 4.59% |
| Eversept Partners, LP | 258,360 | $4,141,511 | 0.57% |
| Alphabet Inc. | 698,262 | $11,193,000 | 0.52% |
| DAFNA Capital Management LLC | 64,235 | $1,030,000 | 0.30% |
| Cormorant Asset Management, LP | 479,988 | $7,694,000 | 0.29% |
| Opaleye Management Inc. | 60,000 | $962,000 | 0.19% |
| Granahan Investment Management | 330,747 | $5,302,000 | 0.19% |
| Artal Group S.A. | 400,000 | $6,412,000 | 0.18% |
| Burrage Capital Management LLC | 15,006 | $241,000 | 0.17% |
| MPM BioImpact LLC | 39,740 | $637,000 | 0.17% |